In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 30 for your search:
Drug:  quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Closed
Age: 10 to 18
Sponsor: Other
Protocol IDs: BMGF48979, ISRCTN98283094, REFCTRI-2009 000137, NCT00923702

2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 13 to 15 at first immunization
Sponsor: Other
Protocol IDs: HPV CSP01, NCT00956553

3.

Phase: Phase IV
Type: Prevention
Status: Completed
Age: 9 to 26
Sponsor: Other
Protocol IDs: 09-000485, NCT01034358

4.

Phase: Phase IV
Type: Health services research, Natural history/Epidemiology, Prevention
Status: Completed
Age: 9 and over
Sponsor: Other
Protocol IDs: MITU-001, NCT01173900

5.

Phase: Phase IV
Type: Prevention
Status: Closed
Age: 16 to 26
Sponsor: Pharmaceutical / Industry
Protocol IDs: V501-110, 132247, NCT01544478

6.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 24 to 45
Sponsor: Pharmaceutical / Industry
Protocol IDs: V501-019, 2004_013, NCT00090220

7.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 11 to 17
Sponsor: Pharmaceutical / Industry
Protocol IDs: V501-025, 2005_092, NCT00325130

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 11 to 17
Sponsor: Pharmaceutical / Industry
Protocol IDs: V501-024, 2005_093, NCT00337428

9.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 45
Sponsor: Pharmaceutical / Industry
Protocol IDs: 108933, NCT00423046

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 9 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: V501-029, 2006_038, NCT00380367

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 9 to 26
Sponsor: Pharmaceutical / Industry
Protocol IDs: V501-030, 2007_021, NCT00496626

12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 9 to 26
Sponsor: Other
Protocol IDs: H07-00928, BCGov-01, NCT00501137

13.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 16 to 26
Sponsor: Other
Protocol IDs: V503-001, 2007_538, NCT00543543

14.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 12 to 26
Sponsor: Other
Protocol IDs: RCH CA27091, NCT00964210

15.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 9 to 26
Sponsor: Pharmaceutical / Industry
Protocol IDs: V501-046, NCT01245764

16.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UHKT-RLP/2011, 2011-002667-14, NCT01375868

17.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 27 and over
Sponsor: NIAID
Protocol IDs: A5298, 11798, NCT01461096

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 16 to 23
Sponsor: Other
Protocol IDs: 2005_086, V502-001, NCT00260039

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 9 to 17
Sponsor: Other
Protocol IDs: V501-028, 2006_052, NCT00411749

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000559149, AMC-052, U01CA121947, 052, NCT00513526

21.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 16 to 26
Sponsor: Other
Protocol IDs: 2007_567, V505-001, NCT00520598

22.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 16 to 26
Sponsor: Other
Protocol IDs: 2007_566, V504-001, NCT00551187

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593634, U01CA121947, AMC-054, NCT00667563

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 12 to 26
Sponsor: NCI
Protocol IDs: 090024, 09-C-0024, NCI-09-C-0024, NCI-P07277, NCT00798265

25.

Phase: Phase I
Type: Educational/Counseling/Training, Prevention, Screening
Status: Completed
Age: 10 to 13 and 30 to 45
Sponsor: Other
Protocol IDs: PERCAPS I, NCT01338051
1   
New Search